Global Yeast Infection Market Companies

Healthcare
Sep 2024
Global
350 Pages
No of Tables: 220
No of Figures: 60

Buy Now

Request for Sample

Nucleus

Companies Covered

Highest Market Share

Dominant Companies

Other Companies

Global Yeast Infection Market Share Analysis

The data presented is for visualization purposes only and may not reflect actual results.

Nucleus : Company Analysis Platform

Request for Demo >

Frequently Asked Questions

Who are major players in yeast infection market?

Companies such as SCYNEXIS, Inc. (U.S.), Merck & Co., Inc. (U.S.), Bayer AG (Germany), Astellas Pharma Inc. (Japan), Thermo Fisher Scientific Inc. (U.S.), are the major companies in the yeast infection market.

What are the recent product launches by major companies in the yeast infection market?

In 2025, international medical societies published updated guidelines for the diagnosis and treatment of Candida infections. These guidelines recommend echinocandins, such as caspofungin, micafungin, anidulafungin, and the newer rezafungin, as first-line therapies for invasive candidiasis due to their broad activity and safety profiles. In addition, oteseconazole has been introduced as a treatment option for recurrent vulvovaginal candidiasis. In December 2021, Cidara Therapeutics, Inc. and Mundipharma announced positive topline results from the pivotal ReSTORE Phase 3 clinical trial, which evaluated the efficacy and safety of rezafungin, a once-weekly antifungal treatment, as a first-line option for candidemia and invasive candidiasis

Which countries data is covered in the yeast infection market?

The countries covered in the yeast infection market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, and rest of Middle East and Africa.